ConductScience.org, home

Paper41019191

Two Sides of Triglycerides in Atherogenesis: An Essential Contributor.

Poznyak AV and 4 others. Clin Med Insights Cardiol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Two Sides of Triglycerides in Atherogenesis: An Essential Contributor. Papers, record 41019191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41019191

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Two Sides of Triglycerides in Atherogenesis: An Essential Contributor.
PubMed
Journal
Clin Med Insights Cardiol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-10-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Poznyak AVAnastasia Vhttps://orcid.org/0000-0002-1516-1320
2Kozlov SSergey
3Babayeva GAGulalek A
4Sukhorukov VNVasily N
5Orekhov ANAlexander N

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124667131The role of hypertriglyceridemia in the development of atherosclerosis and endothelial dysfunction.Nutrients2014https://conductscience.org/library/papers/24667131PubMed
232849290Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/32849290PubMed
338133847Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.Curr Atheroscler Rep2024https://conductscience.org/library/papers/38133847PubMed
425595536Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation.Immunobiology2015https://conductscience.org/library/papers/25595536PubMed
525294122Fibrinolysis and the control of blood coagulation.Blood Rev2015https://conductscience.org/library/papers/25294122PubMed
623874496Association of mitochondrial genetic variation with carotid atherosclerosis.PLoS One2013https://conductscience.org/library/papers/23874496PubMed
732198194Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease.Diabetes2020https://conductscience.org/library/papers/32198194PubMed
837217063Targeting PPARs for therapy of atherosclerosis: A review.Int J Biol Macromol2023https://conductscience.org/library/papers/37217063PubMed
921808658Regulation of microsomal triglyceride transfer protein.Clin Lipidol2011https://conductscience.org/library/papers/21808658PubMed
1023991888Reactive oxygen species in inflammation and tissue injury.Antioxid Redox Signal2014https://conductscience.org/library/papers/23991888PubMed
1122999242Role of lipotoxicity in endothelial dysfunction.Heart Fail Clin2012https://conductscience.org/library/papers/22999242PubMed
1225277507Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.Pharmacol Ther2015https://conductscience.org/library/papers/25277507PubMed
1332752275Lipid Metabolism in Macrophages: Focus on Atherosclerosis.Biomedicines2020https://conductscience.org/library/papers/32752275PubMed
1425054132Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value.Biomed Res Int2014https://conductscience.org/library/papers/25054132PubMed
1534356847The Importance of Lipoprotein Lipase Regulation in Atherosclerosis.Biomedicines2021https://conductscience.org/library/papers/34356847PubMed
1627208823Alterations in triglyceride rich lipoproteins are related to endothelial dysfunction in metabolic syndrome.Clin Biochem2016https://conductscience.org/library/papers/27208823PubMed
1726124928Adiponectin: an adipokine with protective features against metabolic syndrome.Iran J Basic Med Sci2015https://conductscience.org/library/papers/26124928PubMed
1831430977Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders.Int J Mol Sci2019https://conductscience.org/library/papers/31430977PubMed
1932671569Correction to: Lomitapide - a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia.Curr Atheroscler Rep2020https://conductscience.org/library/papers/32671569PubMed
2033483737Relationship between lipoproteins, thrombosis, and atrial fibrillation.Cardiovasc Res2022https://conductscience.org/library/papers/33483737PubMed

See all 76 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42775079Barrier identification and strategic design for hypertriglyceridemia management in the post-acute coronary syndrome patient population at a large integrated health system.Am Heart J Plus2026https://conductscience.org/library/papers/42775079

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41019191

GET https://conductscience.org/api/papers/v1/41019191/references?page=2